Willingness to pay for new Papanicolaou test technologies

American Journal of Clinical Pathology

Volumn 117, Issue 4, 2002, Pages 524-533

  Raab, Stephen S ^a   Grzybicki, Dana Marie ^a   Hart, Alison R ^a   Kiely, Sharon ^a   Andrew JaJa, Carey ^a   Scioscia Jr , Eugene ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Cervical cancer; Cytology; Economic analysis; Preference; Risk; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; FEMALE; HEALTH CARE COST; HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUESTIONNAIRE; UTERINE CERVIX CANCER;

ATTITUDE TO HEALTH; COST-BENEFIT ANALYSIS; FEMALE; FINANCING, PERSONAL; HEALTH CARE COSTS; HUMANS; INCOME; PATIENT SATISFACTION; QUESTIONNAIRES; REIMBURSEMENT MECHANISMS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0036320344     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/XNUG-XH8V-C1KM-T6GD     Document Type: Article

References (65)

1. Improved detection of viral RNA isolated from liquid-based cytology samples
2. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: A study of 7932 women
3. HPV DNA testing of the residual sample of liquid-based Pap test: Utility as a quality assurance monitor
4. New technologies in gynecologic cytology
5. Rapid detection of HSV from cytologic specimens collected into ThinPrep fixative
6. Thin-layer cytology meets viral hybrid capture
7. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results
8. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies
9. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LS1L
10. Recent advances in thin-layer cytology
11. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing
12. Diagnostic performance of hybrid capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study
13. Increased detection of epithelial cell abnormalities by liquid-based gynecologic cytology preparations: A review of accumulated data
14. Multicenter masked evaluation of AutoCyte PREP thin layers with matched conventional smears: Including initial biopsy results
15. CytoRich liquidbased cervical cytologic test: Screening results in a routine cytopathology service
16. Impact of increasing Papanicolaou test sensitivity and compliance: A modeled cost and outcomes analysis
17. Liquidbased cytology for primary cervical cancer screening: A multicentre study
18. The efficacy of liquid-based cervical cytology using direct-to-vial sample collection
19. Biopsy-based comparison of liquid-based, thin-layer preparations to conventional Pap smears
20. Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer
21. ThinPrep Pap Test: Performance and biopsy follow-up in a university hospital
22. Utility of liquid-based cytology for cervical carcinoma screening: Results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma
23. Direct-to-vial use of the AutoCyte PREP liquid-based preparation for cervical-vaginal specimens in three European laboratories
24. Multicenter comparison of manual and automated screening of AutoCyte gynecologic preparations
25. Performance of liquid-based, thin-layer cervical cytology: Correlation with reference diagnoses and human papillomavirus testing
26. Human papillomavirus (HPV) DNA assay as an adjunct to liquidbased Pap test in the diagnostic triage of women with an abnormal Pap smear
27. SpinThin, a simple, inexpensive technique for preparation of thin-layer cervical cytology from liquid-based specimens: Data on 791 cases
28. New technologies in cervical cytology screening: A word of caution
29. The cost-effectiveness of the cytology laboratory and new cytology technologies in cervical cancer prevention
30. Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing
31. Impact of automated technology in the cervical cytologic smear; a comparison of cost
32. Cost analysis of PAPNET-assisted vs conventional Pap smear evaluation in primary screening of cervical smears
33. Clinical and cost implications of new technologies for cervical cancer screening: The impact of test sensitivity
34. Setting the target for a better cervical screening test: Characteristics of a cost-effective test for cervical neoplasia screening
35. Liquid-based cervical-cell collection with brushes and wooden spatulas: A comparison of 100 conventional smears from high-risk women to liquid-fixed cytocentrifuge slides, demonstrating a cost-effective, alternative monolayer slide preparation method
36. Theory versus practice: A review of "willingness-to-pay" in health and health care
37. The contingent valuation method in health care
38. Health care contingent valuation studies: A review and classification of the literature
39. The economic value of a new insulin preparation, Humalog Mix 25: Measured by a willingness-to-pay approach
40. Measurement of consumer preference for treatments used to induce labor: A willingness-to-pay approach
41. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema
42. What are cancer patients willing to pay for prophylactic epoetin alfa?
43. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma
44. The impact of hormone replacement therapy in quality of life and willingness to pay
45. Willingness to pay in treatment of bleeding disorders
46. Measuring heart patients' willingness to pay for changes in angina symptoms
47. Willingness to pay for obesity treatment
48. How much are patients willing to pay to avoid postoperative nausea and vomiting?
49. Willingness to pay for antihypertensive therapy: Results of a Swedish pilot study
50. The willingness to pay for in vitro fertilization: A pilot study using contingent valuation
51. Assessment of asthma patients' willingness to pay for and give time to an asthma self-management program
52. Helicopters, hearts and hips: Using willingness to pay to set priorities for public sector health care programmes
53. The willingness to pay for positron emission tomography (PET): Evaluation of suspected lung cancer using contingent valuation
54. Willingness to pay for mammography: Item development and testing among five ethnic groups
55. The discrete-choice willingness to pay question format in health economics: Should we adopt environmental guidelines?
56. Lightning-related mortality and morbidity in Florida
57. When do the "dollars" make sense? toward a conceptual framework for contingent valuation studies in health care
58. Appraising the use of contingent valuation
59. A test of the equality of closed-ended and open-ended contingent valuations
60. Valuing environmental health effects